APT Pharmaceuticals

edit

APT Pharmaceuticals is a drug development company focused on repurposing well-characterized drugs for under-served populations. APT’s initial focus is on the pulmonary delivery of treatments for serious lung diseases.

Milestones

edit

• 
  APT Pharmaceuticals received $32M in Series A funding. (9/30/08)
  Posted 7/15/09 at 8:30pm

Videos

Screenshots

edit

Above: APT Pharmaceuticals
Uploaded: 7/16/09

Sources

1. APT Pharmaceuticals Secures $32 Million in Series B Financing (aptbio.com) [edit]